About Moshe Rogosnitzky

Real-world Drug Repurposing

Real-world drug repurposing – the immediate “off-label” prescribing of drugs to address urgent clinical needs – is a widely overlooked opportunity, which I am determined to address, so that access to repurposed drugs becomes mainstream. I am one of numerous expert physicians, scientists, government agency officials, and nonprofit leaders around the world who believe that solutions to chronic and life-endangering medical problems lie in the rediscovery and repurposing of widely used, low-cost, and clinically proven safe medicines. Real-world drug repurposing is the only sustainable option to prevent and treat current and future health crises such as the COVID-19 epidemic.

Optimal real-world drug repurposing requires treatment possibilities with a solid track record of safety, affordability, and access.

Fortunately, many thousands of such drugs are already available, however, there is no central repository of off-label drug repurposing information that enables immediate intervention in times of public and personal health crises. My work is focused on changing this and ensuring that life-saving information is freely accessible to all, in real-time.

Research Scientist

As a research scientist, I have had the honor of working on highly rewarding collaborations with researchers at leading academic institutions including:

  • Johns Hopkins University (Baltimore, Maryland)
  • Hershey Medical Center, Penn State University (Hershey, Pennsylvania)
  • University Hospital of Lille (Lille, France)
  • Hadassah University Hospital (Jerusalem, Israel)
  • St. George’s University Hospital (London, U.K.)
  • University of Southern California (San Diego, California)
  • University of Toronto (Toronto, Ontario)
  • Baylor College of Medicine (Houston, Texas)
  • Ariel University (Ariel, Israel)
  • All India Institute of Medical Science (Delhi, India)
  • Postgraduate Institute of Medical Education & Research (Chandigarh, India)

Medical Innovator

An innovator in drug repurposing, I am a named inventor on numerous patents in many therapeutic fields including:

  • SARS
  • Prostate cancer
  • Crohn’s disease
  • Dry eye disease
  • Pterygium
  • Pinguecula
  • Viral conjunctivitis
  • Insomnia
  • Viral infections
  • Hemostasis
  • Androgenic alopecia
  • Erectile dysfunction
  • Pain disorders
  • Medical-information systems.

Consulting & Public Speaking

I have had the honor of collaborating with, consulting with and speaking as a guest at conferences organized by a number of organizations, including:

  • Many Personalized Oncology Expert Panels regarding multiple cancer types (including pancreatic, lung, esophageal, metastatic melanoma, glioblastoma, and sarcoma).
  • Pharmaceutical conferences in North America and Asia, as well as guest lecturing for the Israeli Government Ministry of Health
  • As the Founder and Director of multiple drug repurposing start-ups, I have presented my unique approach to drug repurposing to audiences at Massachusetts Institute of Technology (MIT) in Cambridge, and Charite Health Innovation Summit in Berlin.

Philanthropist & Teacher

  • Since 1999, I have led the preparation of personalized treatment plans for cancer patients that have focused on real-world drug repurposing interfaced with cutting-edge diagnostics to achieve high-impact treatment strategies.
  • I believe that patients should have the knowledge to make informed decisions about their health. I oversee the synthesis of published medical research into comprehensive, consumer-friendly summaries through my work as Co-Founder and Research Director of the non-profit MedInsight Research Institute.
  • At MedInsight, I also created LDNscience.org – the largest physician and patient public information site for Low Dose Naltrexone (LDN) – a treatment that I helped take from obscurity to wide-spread use by more than 500,000 patients worldwide, in more than 60 diseases.

Moshe Rogosnitzky at Work